RT Book, Section A1 Greenberg, Raymond S. A1 Daniels, Stephen R. A1 Flanders, W. Dana A1 Eley, John William A1 Boring, John R. SR Print(0) ID 545732 T1 Chapter 7. Clinical Trials T2 Medical Epidemiology, 4e YR 2005 FD 2005 PB The McGraw-Hill Companies PP New York, NY SN 9780071416375 LK accesspharmacy.mhmedical.com/content.aspx?aid=545732 RD 2024/04/18 AB A clinical trial is the direct comparison of two or more treatment modalities in human groups. Evidence-based medicine is the integration of current best evidence with clinical expertise, pathophysiological knowledge, and patient preferences to make health decisions. The practice of evidence-based medicine is encouraged because it may lead to more consistent and objective clinical decisions. A type I error occurs when a study finds a difference in effectiveness between the treatments being compared when in fact no difference exists. A type II error occurs when a study fails to find a difference in treatment effectiveness between the treatments being compared when in fact a difference does exist. Statistical power is the ability of a study to detect a true difference between groups being compared. When treatments are assigned by randomization, probability alone determines assignment, rather than the personal preferences of either physicians or patients. When patients are unaware of their treatment assignment in a clinical trial, it is referred to as a single-blinded study. In a double-blinded study, neither the patients nor the treating physicians know individual treatment assignments. A ratio of either rates or risks can be used to compare the outcomes in the experimental and control groups. Meta-analysis is a statistical integration of the results of several independent studies. A sensitivity analysis can be used to determine whether differences across studies may be explained by characteristics of the various populations studied.